According to Zhitong Finance App News, Jiuzhitang (000989.SZ) released its report for the third quarter of 2026. The company achieved operating income of 2,186 billion yuan in the first three quarters, up 34.34% year on year; net profit attributable to shareholders of listed companies was 304 million yuan, up 100.33% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 276 million yuan, up 110.63% year on year; basic earnings per share were 0.3587 yuan. The company's revenue growth was mainly due to the increase in sales of some of the company's products in the current period and the inclusion of Harbin Jixianglong Biotechnology Co., Ltd. in the scope of the merger starting in November 2025.